The global peritoneal dialysis market is driven by factors such as growing prevalence of ESRD (End-stage Renal Disease) and increasing geriatric population prone to medical conditions such as acute diabetes and elevated blood pressure which would lead to kidney or renal failure. Furthermore, favorable government initiatives such as R&D funding, improving reimbursement policies, and increasing demand for technologically advanced treatment procedure is also fueling the market growth. Moreover, growing unmet healthcare needs, increasing availabilities & accessibilities to the products & services of peritoneal dialysis treatment, and rising demand for cost-effective, minimally invasive treatment are few factors that are boosting market growth over the forecast period. However, high failure rates, risk of infection, and permanent catheter placement outside the body delivery are some factors that are expected to impede market growth.
Based on types of products, the peritoneal dialysis market is segmented into implantation systems, peritoneal solution, peritoneal dialyzers, peritoneal dialysis catheters, and other accessories constitute. In 2014, peritoneal dialyzers were the highest revenue earning product segment of the market. Rising incidences of diseases such as diabetes and hypertension which leads to kidney disorders and growing demand for minimally invasive surgeries are few factors that are driving the market growth. Moreover, growing geriatric population with various disorders such as swelling, inflammation, and infection of the kidney and growing government initiatives to improve healthcare infrastructure are few factors that are expected to positively reinforce market growth. On the basis of types of services provided, the market is segmented into homecare services and education about the peritoneal dialysis process. In 2014, homecare services were the highest revenue-generating service type. Growing aging population with long term care requirements, increasing awareness regarding hospital-acquired infections and rising usage of technologies among patients are few factors that are expected to boost usage rates. Furthermore, increasing demand for cost-effective medical equipment and increasing prevalence of end-stage renal diseases (ESRD), kidney failure or renal failure are few factors that are expected to positively impact market growth.
Based on types of applications, the peritoneal dialysis market is segmented into automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD). Presently, CAPD held the majority market share in terms of revenue. Growing demand for machine less invasive treatment and rising awareness regarding the significance and importance of ESRD are few factors that are responsible for its largest share. Additionally, factors that are expected to boost the market include increasing prevalence of renal failure due to stress, hypertension, and diabetes mellitus, increasing demand for the no set time & hassle-free treatment procedure, and increasing population with comorbidity.
North America, MEA, Latin America, Europe, and Asia Pacific are the key regional markets. In 2014, North America was the largest market in terms of revenue owing to growing prevalence of chronic disorders such as diabetes and hypertension pertaining to kidney failure and thus increasing demand for peritoneal dialysis. Moreover, rising demand for advanced peritoneal dialysis technology and increasing government initiatives by organization such as the International Society of Peritoneal Dialysis (ISPD), the Fresenius Medical Care (FMC), and the American Society of Nephrology (ASN) are few factors that are attributing for its largest share. However, Asia Pacific is expected to be the fastest-growing region over the forecast period. Presence of unmet healthcare needs and rising awareness campaign regarding peritoneal dialysis by agencies such as the Hong Kong Society of Nephrology (HKSN), the Asia Pacific Society of Nephrology, and the ISPD-APC are some factors that are expected to boost the market.
Key players of the peritoneal dialysis market include B. Braun Melsungen, Baxter International, DaVita Healthcare Partners, Fresenius Medical Care, Covidien, Dialysis Clinic, Diversified Specialty Institute Holdings, Huaren Pharmaceutical, Medical Components, NephroPlus, Nipro, Northwest Kidney Centers, NxStage Medical, Renal Services, Sandor, Satellite Healthcare, Sichuan Kelun Pharmaceutical, and U.S. Renal Care.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.